TNFRSF21 and chronic kidney disease: The association of DR6 remains significant (padjusted = 0.0196, ORadjusted 1.43, 95% CI 1.06–1.94) when conditioned on the clinical characteristics, suggesting the independent association of DR6 with CKD in RA patients.